BioCryst

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioCryst and other ETFs, options, and stocks.

About BCRX

BioCryst Pharmaceuticals, Inc. is a commercial-stage biotechnology company that discovers novel, oral, and small-molecule medicines. The firm focuses on the treatment of rare diseases in which unmet medical needs exist and an enzyme in the biological pathway of the disease. 

CEO
Jon P. Stonehouse
CEOJon P. Stonehouse
Employees
358
Employees358
Headquarters
Durham, North Carolina
HeadquartersDurham, North Carolina
Founded
1986
Founded1986
Employees
358
Employees358

BCRX Key Statistics

Market cap
2.00B
Market cap2.00B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
2.27M
Average volume2.27M
High today
$11.12
High today$11.12
Low today
$10.56
Low today$10.56
Open price
$10.89
Open price$10.89
Volume
2.49M
Volume2.49M
52 Week high
$19.99
52 Week high$19.99
52 Week low
$7.61
52 Week low$7.61

BCRX News

Simply Wall St 7d
Institutional investors are BioCryst Pharmaceuticals, Inc.'s biggest bettors and were rewarded after last week's US$181m market cap gain - Simply Wall St

If you want to know who really controls BioCryst Pharmaceuticals, Inc. ( ), then you'll have to look at the makeup of its share registry. With 72% stake, instit...

Institutional investors are BioCryst Pharmaceuticals, Inc.'s biggest bettors and were rewarded after last week's US$181m market cap gain - Simply Wall St

Analyst ratings

50%

of 12 ratings
Buy
50%
Hold
50%
Sell
0%

BCRX Earnings

-$0.40
-$0.27
-$0.13
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 23, Pre-Market
ActualExpected Feb 23, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.